279 related articles for article (PubMed ID: 34292585)
1. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
2. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
Knackstedt TJ
J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities.
Kim TH; Kim HJ; Seo JW; Song KH
Br J Dermatol; 2020 Feb; 182(2):427-433. PubMed ID: 31077333
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
[TBL] [Abstract][Full Text] [Related]
5. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
Levoska MA; Schmults CD; Waldman AH
Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
[TBL] [Abstract][Full Text] [Related]
6. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
7. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
8. Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery.
Cheraghlou S; Doudican NA; Criscito MC; Stevenson ML; Carucci JA
J Am Acad Dermatol; 2022 Dec; 87(6):1422-1425. PubMed ID: 35987400
[No Abstract] [Full Text] [Related]
9. Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
Aiken TJ; Stahl CC; Schwartz PB; Barrett J; Acher AW; Lemaster D; Leverson G; Weber S; Neuman H; Abbott DE
J Surg Oncol; 2021 Jan; 123(1):104-109. PubMed ID: 32939750
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Cutaneous Melanoma of the Head and Neck With Wide Local Excision Versus Mohs.
Namin AW; Oudin EM; Tassone PT; Galloway TLI; Dooley LM; Zitsch RP
Laryngoscope; 2021 Nov; 131(11):2490-2496. PubMed ID: 33844289
[TBL] [Abstract][Full Text] [Related]
11. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
13. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
14. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
[TBL] [Abstract][Full Text] [Related]
16. Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma.
Nguyen B; Karia PS; Hills VM; Besaw RJ; Schmults CD
Dermatol Surg; 2018 Apr; 44(4):493-501. PubMed ID: 29059142
[TBL] [Abstract][Full Text] [Related]
17. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
19. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]